°ÐµãµÄ·¢Ã÷ºÍÈ·ÈÏ£¬¹ØÓÚҩѧÊÂÇéÕß¶øÑÔ£¬ÊÇÒ»Ïî¼ÈÖ÷ÒªÓÖÄÑÌâµÄʹÃü£¬Í¨³££¬Ò©Îï×÷ÓõÄаеãÒ»µ©±»·¢Ã÷£¬ÍùÍù»á³ÉΪһϵÁÐÐÂÒ©·¢Ã÷µÄÍ»ÆÆ¿Ú¡£ÓÚÊÇ£¬ÔÚѰÕÒеÄÒ©Îï°ÐµãÉÏ£¬¸÷¹ú¿ÆÑÐְԱȫÁ¦ÒÔ¸°£¬¸÷´óÒ©Æó·×·×ͶÈëÖØ½ð¾ÙÐÐÖÖÖÖÊÔÑ飬ÒÔÆÚÄܹ»Í¨¹ýÕÒµ½Ò»¸öеÄÒ©Îï°Ðµã¶øÑз¢³öÓâÔ½µÐÊÖµÄÐÂÒ©¾ºÆ·¡£È»¶ø£¬Ê§°ÜµÄ½Ìѵ¸æËßÎÒÃÇ£¬²¢·Çÿһ¸ö¹¦Ð§Ð͵ÄÉúÎï´ó·Ö×Ó£¬¶¼¿ÉÒÔµ±×öÒ©Îï°ÐµãÈ¥¾ÙÐпª·¢£¬ÉúÎï´ó·Ö×ÓÖ»ÓоßÓÐÒ»¶¨µÄÌØµã£¬²Å¿ÉÒÔ±»ÎÒÃÇËø¶¨¼Ì¶ø¿ª·¢³É°Ð¡£ÒÔÊÇ£¬Ò©Îï°ÐµãµÄѧϰ¡¢Ã÷È·ºÍ¸ÐÎò£¬¹ØÓÚÿ¸öÐÂÒ©Ñз¢Ö°Ô±£¬¾ÍÏԵøñÍâÖ÷Òª¡£
1. ʲôÊÇ¡°Ò©Îï°Ðµã¡±£¿Ó¦¾ß±¸ÔõÑùµÄ»ù±¾Ìõ¼þ£¿
ÔçÔÚ1891Ä꣬PaulEhrlich(¿¹ÉúËØ·½ÃæÐ¢Ë³Í»³ö)ÆäʱÕýÔÚʵÑéÓÃȾÁÏȾɫϸ¾úϸ°û£¬Ê±´úÌá³ö£¬¡°Ï¸°û¿ÉÄÜÊÇÒ»¸ö¡®´ó·Ö×Ó¡¯£¬ÕâÖÖ¡®Ï¸°û-·Ö×Ó¡¯±£´æ¡®²àÁ´¡¯À´ÎüÊÕÍⲿµÄÓªÑø¡±£¬²¢½«ÆäÃüÃûΪ¡°²àÁ´ÊÜÌ塱¡£Paul EhrlichÏàÐÅ£¬Ï¸¾ú±£´æÊÜÌå²¢¿ÉÓëȾÁÏ·Ö×Ó±¬·¢»¯Ñ§·´Ó¦£¬ËæºóÔÚ½ÓÏÂÀ´µÄÊÔÑéÖУ¬ÓÖÏà¼ÌÌá³öÁË¡°»¯ÁÆ¡±ÒÔ¼°¡°Ò©ÎïÊÇͨ¹ý×÷ÓÃÓڰеã·Ö×Ó¶ø±¬·¢×÷Óᱵȿ´·¨ºÍ¼Ù˵¡£ÏÖÔÚ£¬ÕâÒ»¿´·¨ÈÔÈ»±£´æ£¬Å£½òÉúÎﻯѧ´ÇÊ齫¡°Ò©Îï°Ðµã¡±½ç˵Ϊ¡°ÓëÌØÊ⻯ºÏÎïÏ໥×÷Óò¢±»µ÷ÀíµÄÉúÎïʵÌ壬ͨ³£ÎªÂѰ׻ò»ùÒò¡±¡£ÔÚÄÇÖ®ºó£¬Ò»ÏµÁÐÓëÖ®Ïà¹ØµÄѧ˵Ïà¼Ì±¬·¢£¬ÆäÖб£´æÒ»¶¨Îóµ¼ÐԵļ´ÊÇ¡°Ò»¸öÒ©Îï¶ÔÓ¦Ò»¸ö°Ðµã£¬ÇÒÕâ¸ö°ÐµãÊÇÌØÊâÇÒΨһµÄ¡±¡¡Ëæ×Å¿ÆÑ§µÄһֱǰ½ø£¬ÓÈÆäÊÇÒ©ÀíѧµÄÒ»Ö±Éú³¤£¬´ó²¿·Ö¼Ù˵²»¹¥×ÔÆÆ¡£
Ëæ×Å¿ÆÑ§µÄÒ»Ö±Éú³¤£¬ÏÖÔÚÒ©Îï°Ðµã»ù±¾¿É½ç˵Ϊ¡°Äܹ»ÓëÌØ¶¨Ò©ÎïÌØÒìÐÔÁ¬Ïµ²¢±¬·¢ÖÎÁƼ²²¡×÷Óûòµ÷ÀíÐÄÀí¹¦Ð§×÷ÓõÄÉúÎï´ó·Ö×Ó»òÉúÎï·Ö×ӽṹ¡±¡£ÓÉ´Ë¿ÉÖª£¬Ò©Îï°ÐµãÍùÍùÊÇÉúÎï´ó·Ö×Ó£¬²¢¾ßÓкÍÒ»Ð©ÌØÊ⻯ºÏÎïÄܹ»¡°Á¬ÏµµÄ²¿Î»¡±£¬µ±ÏìÓ¦»¯Ñ§ÎïÖÊÓëÖ®±¬·¢Á¬Ïµºó£¬½á¹¹»á±¬·¢Êʵ±µÄת±ä£¬ÇÒÕâ¸öת±ä×îºÃÊÇ¡°¿ÉÄæµÄ¡±¡£½á¹¹×ª±äºóµÄÕâ¸öÉúÎï´ó·Ö×Ó£¬»áʩչһ¶¨µÄÐÄÀí²¡Àí×÷Ó㬼´ÌåÏÖ³ö¡°Ò©Ð§¡±£¬ÇÒÔÚ»úÌåÖØ´óϵͳÖÐÕ¼ÓÐÖ÷µ¼×÷Ó᣶ø²¡ÀíÌõ¼þÏ£¬¸ÃÎïÖʵıí´ï¡¢»îÐÔ¡¢½á¹¹»òÌØÕ÷¿ÉÒÔ±¬·¢×ª±ä£¬ÕâÖÖת±ä¿ÉÒÔÊÇÔ·¢ÐÔ£¬Ò²¿ÉÒÔÊǼ̷¢ÐԵġ£±ðµÄ£¬ÔÚÌåÄÚ¿ÉÄܱ£´æÄÚÔ´ÐÔÒ²¿ÉÄܱ£´æÍâÔ´ÐÔµÄÄÜÓë¸Ã·Ö×Ó»ò½á¹¹Á¬ÏµµÄÎïÖÊ£¬Õâ¸öÁ¬ÏµµÄÎïÖÊ¿ÉÒÔ×÷ΪҩÎïÓÃÓÚ·ÀÖμ²²¡¡£ÒÔÉÏ¿ÉÒÔ˵£¬ÊÇÒ»¸öÉúÎï´ó·Ö×Ó×÷ΪҩÎï°Ðµã×îΪ»ù±¾µÄÌõ¼þ£¬ËäÈ»£¬Ò»¶¨Ìõ¼þ×ÔÈ»ÊDZ£´æÏìÓ¦µÄ¡¢ºÏÊʵÄÒ©Îï¡£
2. ½üÄêÀ´£¬Ò©Îï°ÐµãµÄÉú³¤ÇéÐÎ
ÓÉÓÚÒ©Îï°ÐµãµÄÖ÷Òª¼ÛÖµºÍ×÷Ó㬽üÄêÀ´£¬Ëæ×Å·Ö×ÓÉúÎïѧ¡¢ÈËÀà»ùÒò×é¡¢ÂѰ×ÖÊ×éµÈÉúÃü¿ÆÑ§ºÍÊÖÒÕÒªÁìµÄÉú³¤£¬ÈËÃǶÔÒ©Îï°ÐµãµÄÑо¿ÈÈÇé¿Õǰ¸ßÕÇ£¬Ò©Îï°ÐµãµÄ·¢Ã÷ºÍÈ·Ö¤¼º¾³ÉΪÉúÃü¿ÆÑ§ÁìÓòÑо¿ÈÈÃÅ¡£ÇÒÆ¾Ö¤ÈËÀà»ùÒò×éÑо¿Ð§¹ûÕ¹ÍûµÄϸ°ûÄÚÒ©Îï·Ö×ÓÄÜ×÷Óõİе㣬¾ÝÊØ¾ÉÔ¤¼Æ£¬Äܹ»³ÉΪҩÎï°ÐµãµÄÔ¼ÓÐ5000¡«10000¸ö£¬ÕâЩ°Ðµã×ã¹»¿ÆÑÐÖ°Ô±ÃÆÍ·Ñо¿Ò»¶Îʱ¼äÁË¡£
2016Ä꣬¡¶Nature Reviews Drug Discovery¡·µÄÁ½ÆªÎÄÕÂÆÊÎöÁË2016Äê°ÐµãµÄÑо¿ÇéÐΣ¬ÆäÖÐһƪ¹²Éæ¼°661¸ö°Ðµã(ÈËÀàÂѰ×)£¬285¸öΪ¾ÓÉÑéÖ¤µÄ°Ðµã£¬376¸öΪае㣻Áíһƪ¹²Éæ¼°893СÎÒ˽¼ÒÀàºÍ²¡ÔÌåÑÜÉúµÄÉúÎï·Ö×Ó(ͳ¼ÆFDAÅú×¼µÄ1578¸öÒ©Îï)£¬°üÀ¨667СÎÒ˽¼ÒÀà»ùÒò×éÑÜÉúÂѰף¬ÕâЩ°Ðµãµ±ÖУ¬GÂѰ׿ÁªÊÜÌå¡¢Àë×ÓͨµÀ¡¢¼¤Ã¸¡¢ºËÊÜÌåµÄÑо¿Ïà¶Ô½Ï¶à¡£
3. °ÐµãÈ·Ö¤µÄ¼ÛÖµºÍÒâÒå
½ñÌ죬̽Ë÷Ò©Îï°ÐµãµÄÒªÁìÒѾÓÐÐí¶àÐí¶à£¬¶øÓÉÓڰеãÔÚÒ©Îï·¢Ã÷Àú³ÌÖеÄְλºÍ¼ÛÖµ£¬ÈËÃÇÖð½¥½«¹Ø×¢µã¾Û½¹ÔÚÁ˰еã¼òÖ±ÈÏÉÏ¡£¶ø°Ðµã¼òÖ±ÈÏ×ÔÈ»Àë²»¿ªÒ»Ð©ºÏÊʵķÖ×Ó£¬Í¨¹ý¡°»ùÓڰеãµÄɸѡսÂÔ¡±ºÍ¡°±íÐÍɸѡսÂÔ¡±¿ÉÒÔÏÈɸ³öһЩ¸ÐÐËȤµÄºòѡҩÎï£¬Ëæºó¶Ô°Ðµã¾ÙÐÐÈ·ÈÏ¡¢ÑéÖ¤£¬Ê¹Ö®³ÉÎªÕæÕýÒâÒåÉϵġ°Ò©Îï°Ðµã¡±¡£
¹ØÓڰеãµÄÑéÖ¤Àú³Ì£¬¼òÒªÏÈÈÝÈçÏ£ºÊ×ÏÈ£¬È·ÈϰеãÔÚϸ°ûʵÑéÖÐÊÇ·ñ¾ßÓе÷Àí»¯ºÏÎïµÄÉúÎï»îÐÔ£¬Õâ¿Éͨ¹ýRNA×ÌÈÅÊÖÒÕĬȻijһ»ùÒò(СÊó)£¬ÊÓ²ìÊÇ·ñ¾ßÓÐÒ©Îï×÷ÓúóµÄÖ¢×´£¬ÈôÒ©ÎïûÓÐÒýÆðЧӦ£¬ËµÃ÷Ò©ÎïÊÇͨ¹ýÕâÒ»ÌØ¶¨°Ðµã×÷Óõġ£Òò´Ë£¬ºòÑ¡°ÐµãµÄͬϵÎïÒ²Òª±»ÄÉÈë˼Á¿¹æÄ££¬×ÝÈ»ÆäÔÚ×î³õµÄɸѡÖв¢Ã»Óб»Ê¶±ð¡£±ðµÄ£¬Ò»¸öÎïÖÊ¿ÉÄܾßÓй¦Ð§ÐÔ»ñµÃµÄ»îÐÔ£¬°ÐµãµÄȱʧÒà»áÒÖÖÆ´ËÎïÖʵĻîÐÔ¡£³ýÁËRNA×ÌÈÅÊÖÒÕ£¬Ò²¿ÉÒÔÓÃcDNA¹ý±í´ïÀ´½¨ÉèÒ©Îï-°Ðµã×÷ÓùØÏµ£¬ÕâÖÖÒªÁìÀàËÆÓÚ½ÍĸÖеĿ½±´ÊýÒÖÖÆÕ÷Ï󣬰еãµÄ¹ý±í´ï¿ÉÄÜ»áÒÖÖÆÒ©ÎïµÄ»îÐÔ£¬ÕâÖÖÒªÁì¹ØÓÚÑé֤Ĥ°Ðµã¼«ÎªÖ÷Òª¡£Ò»µ©¼Ù¶¨µÄ°Ðµãͨ¹ý¹¦Ð§ÊµÑéµÄÑéÖ¤£¬¾ÍÐèÒª¶ÔС·Ö×ÓÎïÖʼ°°ÐµãµÄÇ׺ÍÁ¦¾ÙÐÐÁ¿»¯¡£ÕâÒ»Àú³Ì¿ÉÒÔͨ¹ýÍâòµÈÀë×Ó¹²Õñ»òÕßµÈÎÂÁ¿ÈÈ·¨ÊÖÒÕÍê³É£¬ÈôÊǼٶ¨µÄ°ÐµãÊÇÒ»ÖÖø£¬ÔòҪͨ¹ýø¶¯Á¦Ñ§ÊµÑéȨºâ´ËÎïÖʵÄø»îÁ¦¡£×îºó£¬ÐèҪͨ¹ýNMR»ò¹²½á¾§ÊµÑé¾ÙÐиüΪÑÏ¿áµÄÑéÖ¤£¬½ø¶ø»ñµÃÒ©Îï-°Ðµã¸´ºÏÎïµÄÈýά½á¹¹¡£ÕâЩÐÅÏ¢²»µ«¿ÉÒÔÑéÖ¤ÎïÀíÉϵĹØÁªÐÔ£¬Ò²¿ÉÒÔÌṩºóÆÚÒ©ÎïÓÅ»¯ÖÐÁ¬ÏµÄ£×ÓµÄÅжϱê×¼¡£
4. °Ðµã·ÖÀà~¡°Ò©Îï¡¢ºòѡҩÎDZÔÚÒ©Îï°Ðµã¡± & ¡°ÌØÒì¡¢Ö÷µ¼¡¢ÓÅÊÆÒ©Îï°Ðµã¡±
ͨ¹ýÒ©Îï°ÐµãµÄÌØµã£¬Ðí¶àÈ˽«Ò©Îï°Ðµã·Ö³ÉÈýÀ࣬¼´¡°Ò©Îï°Ðµã¡¢ºòѡҩÎï°Ðµã¡¢Ç±ÔÚÒ©Îï°Ðµã¡±¡£ËùνҩÎï°Ðµã£¬Í¨³£ÊÇÖ¸ÄÇЩÒѾȷÈÏÁ˵ÄÌØ¶¨Ò©ÎïµÄ×÷Óðе㣻ËäÈ»£¬ÈôÊÇÏìÓ¦Ò©ÎﻹûÓÐÑз¢Àֳɡ¢ÉÏÊУ¬Ò²²»¿É˵¾Í²»ÊÇÒ©Îï°Ðµã£¬ÕâЩÒѾ߱¸ÁËÒ©Îï°Ðµã»ù±¾ÌØÕ÷µÄÉúÎï´ó·Ö×Ó»ò·Ö×ӽṹ£¬ÉÐÐèÒ»Ö±µÄÑо¿¡¢ÆÀ¼Û£¬¹Ê³ÆÖ®ÎªºòѡҩÎï°Ðµã£»¶øÇ±ÔÚÒ©Îï°Ðµã£¬ÊÇÖ¸ÄÇЩ½ö·¢Ã÷Á˲¿·ÖÒ©Îï°ÐµãµÄÌØÕ÷£¬µ«Éв»¾ß±¸Ò©Îï°ÐµãµÄ´ó¶¼Ìõ¼þ£¬ºÃ±È˵ÓÐЩ¾ßÓÐÖ÷Òª¹¦Ð§µÄÂѰ×ÖÊ£¬¾ß±¸²¿·ÖÒ©Îï°ÐµãµÄÌØÕ÷£¬¿ÉÒÔ×÷Ϊһ¸öDZÔÚµÄÒ©Îï°Ðµã¡£ÉÐÓÐһЩÂѰ×ÖÊ£¬ËäÈ»·¢Ã÷ÁËһЩ¹¦Ð§£¬µ«ÉÐûÓÐÊìϤµ½Ò©Îï°ÐµãÏà¹ØµÄ¸ü¶àµÄÌØÕ÷£¬ÕâЩÎïÖʱ»³ÆÎªÒ©Îï°Ðµã¾ÍÌ«ÔçµãÁË£¬³äÆäÁ¿¾ÍÊÇÒ»¸ö¹¦Ð§ÂѰס£
¶øÆ¾Ö¤×÷ÓÃÓڰеãÉϵÄÒ©ÎïµÄ×÷ÓÃÌØµã£¬ÓÖ¿ÉÒÔ½«Ò©Îï°Ðµã·ÖΪ¡°ÌØÒìÒ©Îï°Ðµã¡¢Ö÷µ¼Ò©Îï°Ðµã¡¢ÓÅÊÆÒ©Îï°Ðµã¡±¡£ËùÎ½ÌØÒìÒ©Îï°Ðµã£¬¼´ÊÇÖ¸×÷ÓÃÓÚÕâÀà°ÐµãÉϵÄÒ©Îï¿ÉÒÔʩչºÜºÃµÄÒ©Àí×÷Ó㬵ִïÀíÏëµÄ·ÀÖμ²²¡µÄЧ¹û(ÆäÖаüÀ¨Ñ¡ÔñÐÔ¡¢°ÐÏòÄÚÈÝ)£»¶øÖ÷µ¼Ò©Îï°Ðµã£¬¾ÍÊǸðеãµÄÐÄÀí¡¢²¡Àí¡¢Ò©Àíѧ¹¦Ð§ÔÚ»úÌåµ÷ÀíÖÐÕ¼ÓÐÖ÷µ¼Ö°Î»£»ÉÐÓÐÒ»Àà¿ÉÒÔ³ÆÎªÓÅÊÆÒ©Îï°Ðµã£¬ÊÇÖ¸ÔÚÐÄÀí²¡ÀíÌõ¼þ϶ԻúÌåµÄµ÷Àí¾ßÓÐÓÅÊÆÖ°Î»£¬×÷ÓøðеãµÄÒ©ÎïÔÚʩչҩÀí×÷ÓõÄͬʱ£¬¿ÉÄÜÊܵ½»úÌåÕûÌåÒòËØµÄÓ°Ï죬¶øÌåÏÖ³öÀ´µÄ×÷ÓÃÒà¿ÉÄܱ»×ÌÈÅ£¬ÕâÀàÒ©Îï°Ðµã¿ÉÒÔ³ÆÎªÓÅÊÆÒ©Îï°Ðµã¡£
5. µ±ÏµİеãÑо¿±£´æÄÄЩÎÊÌâ
°Ðµãɸѡ²»ÑÏ
Ê×ÏÈ£¬ºòÑ¡»¯ºÏÎïÄܹ»Óë´ý¿ª·¢µÄÉúÎï´ó·Ö×ÓÁ¬Ïµ£¬²¢²»´ú±í¸ÃÉúÎï´ó·Ö×Ó¼´ÎªÒ©Îï°Ðµã¡£Ðí¶àÉúÎïÖÆÒ©¹«Ë¾ºÍÑз¢»ú¹¹ÔÚδȡµÃ¿ÆÑ§µÄͳ¼ÆÑо¿Êý¾ÝµÄÇéÐÎÏ£¬½öƾ֤ÉÙÊý¼¸¸ö¼òªµÄʵÑéЧ¹û¾ÍÒÔΪ¸Ã°Ðµã¾ßÓкܺõĿª·¢Ô¶¾°£¬´Ó¶ø´ó¹æÄ£µØ¿ªÕ¹Á¢ÒìÒ©ÎïµÄÑз¢ÊÂÇé¡£
Ñз¢±ÜÄѾÍÒ×
Ïà¶ÔÈÝÒ׿ª·¢µÄ°Ðµã£¬ÍùÍù»á»ñµÃÒ»ÎÑ·äµÄÔú¶ÑÑо¿£¬ºÜÈÝÒ×Ñо¿¹ýÍ·£¬¶øÊ£ÏµÄһЩ¿ª¾ÙʶȽϴóµÄÉúÎï´ó·Ö×Ó£¬ÔòµÃ²»µ½ÓÅÊÆÑз¢ÊµÁ¦µÄ½øÈ룬ÈçÂþÑÜÓÚ¶à×éÖ¯»òÓë¶à¸öµ÷Àíͨ·Óйصİе㣬ʹµÃÑз¢×ÊÔ´±£´æÆÌÕÅ¡£
ÔçÆÚ¿ª·¢Ï꾡
×éºÏ»¯Ñ§¡¢¸ßͨÁ¿É¸Ñ¡±»¼ÄÓèÁËÌ«´óµÄÏ£Íû£¬Ðí¶àÖÆÒ©¹«Ë¾ÒÔΪÔÚ¾ÙÐÐÈËÌåÊÔÑé֮ǰ³ä·ÖµØÊ¹ÓÃÕâЩÏȽøµÄÊÖÒÕÀ´ÅªÇåÒ©ÎïÓë°ÐµãµÄ×÷ÓûúÖÆºÍ¿ÉÄܱ¬·¢µÄ¶¾Àíѧ¡¢Ò©¶¯Ñ§ÎÊÌ⣬´Ó¶øÊµÏÖÒ©ÎïÓÅÑ¡µÄ×î´ó»¯£¬ÕâÑùÒ²¾ÍÎÞÐεØÔöÌí°Ðµã¿ª·¢µÄʱ¼ä²¢½µµÍÁËÐÂÒ©ÉÏÊеÄËÙÂÊ¡£
±»ºòÑ¡»¯ºÏÎï¡°¿Ó¡±
´ý¿ª·¢µÄÉúÎï´ó·Ö×ÓÊÇ·ñÄܳÉΪҩÎï°Ðµã£¬ÊÇÐèÒªºòÑ¡»¯ºÏÎïÀ´Ö¤ÊµµÄ£¬¶øÓÐЩ»¯ºÏÎïÌìÉú¾Í±£´æÒ»Ð©¡°²Ð¼²¡±£¬ÈçÌåÄÚ´úл½Ï¿ì¡¢º¬»ùÒò¶¾½á¹¹µÈ£¬µ¼ÖÂDZÔÚµÄÒ©Îï°ÐµãҲͬ²½µÄ±»¿ÓµôÁË¡£
6. ÏÖÔÚÄÄЩÊý¾Ý¿â¿ÉÖ§³ÖÒ©Îï°ÐµãÑо¿£¿
´óÊý¾ÝÇéÐÎ֮ϣ¬Ò©Îï°ÐµãÑо¿ÒàÔÚÆäÖУ¬Êý¾Ý×ÊÔ´µÄÍÚ¾òºÍʹÓã¬ÒѳÉΪ·¢Ã÷Ò©Îï°ÐµãµÄÖ÷Ҫ;¾¶¡£Ëæ×ÅÉúÃü¿ÆÑ§ºÍÉúÎïÐÅϢѧµÄÉú³¤£¬Ô½À´Ô½¶àµÄ°Ðµã½á¹¹»ñµÃÆÊÎö£¬Ê¹Ò©Îï°ÐµãÊý¾Ý¿âµÄ¹¹½¨¾ßÓÐÐëÒªÐÔ¼°¿ÉÄÜÐÔ¡£¹¦Ð§»ùÒò×éѧ¡¢ÂѰ××éѧ¡¢ÏµÍ³ÉúÎïѧ¡¢¶àÏòÒ©Àíѧ¡¢ÍøÂçÒ©ÀíѧµÈÀíÂÛµÄÌá³ö£¬ÒÔ¼°ÅÌËã»ú¸¨ÖúÒ©ÎïÉè¼Æ£¬ÅÌËã»úÐéÄâɸѡµÈÅÌËã»úÊÖÒÕµÄÓ¦Ó㬶ÔÒ©Îï°ÐµãÊý¾Ý¿âÌá³öÁ˸ü¸ßµÄÒªÇó£¬Íƶ¯Ò©Îï°ÐµãÊý¾Ý¿â½øÒ»²½Éú³¤¡£Ò©Îï°ÐµãÊý¾Ý¿âÍøÂçºÍÕûÀíµÄÒ©Îï°ÐµãÐÅÏ¢²»¾¡Ïàͬ£¬µ«Ö÷ÒªÓÐ2À࣬һÊÇÕë¶ÔÒÑ֤ʵµÄÒ©Îï°Ðµã¾ÙÐÐÕûÀí¼°ÖÎÀí£¬ºÃ±È Drug Target Database¡£¶þÊdzýÁË֤ʵµÄÒ©Îï°ÐµãÍ⣬»¹°üÀ¨Ç±ÔÚµÄÒ©Îï°ÐµãµÄÊý¾Ý¿â£¬ºÃ±ÈTTD¡£
7. СС¸ÐÎò
¡°¹«¹²´´Òµ¡¢ÍòÖÚÁ¢Ò족£¬ÖÆÒ©ÐÐÒµËäΪ¹Å°å£¬µ«Á¢Òì³ÌÐòÒ಻¿É»òȱ¡£ÔÚ¹ú¼ÒÃãÀø¡¢Ö§³Ö´´Á¢ÎÒÃÇ×Ô¼ºµÄ¡°ÐÂÒ©¡±Ö®Ê±£¬¸÷´ó¿ÆÑÐÔºËù¡¢¸ßУ¡¢Ò©ÆóÒà¸Ä±äÑз¢Æ«Ïò£¬ÔÚÐÂÒ©µÄ´´Ôì·½Ãæ¼Ó´óͶÈ룬²ã²ã¼Ó×¢¡£¹ØÓÚ´ÓÊÂÐÂÒ©Ñз¢µÄ¿ÆÑÐÖ°Ô±À´Ëµ£¬Ò²Ðí×îÔçµÄ¡°ÐÂÒ©¡±¿´·¨£¬Àë²»¿ªÈý¸ö×Ö¡°»¯ºÏÎ£¬¶ø³ÌÐò×ÔÈ»¾ÍÊDzéÎÄÏס¢Ïàʶ°Ðµã¡¢Éè¼ÆÄ¸ºË¡¢ÆÌÌì¸ÇµØµÄ»¯ºÏÎïÊýÄ¿¡¢·¢Ã÷Ïȵ¼¡¢½á¹¹ÓÅ»¯......µÈµÈµÈµÈ£¬¸ü¶àµÄ¾«Éñ¿ÉÄÜ»á·ÅÔÚ×ö»¯ºÏÎï¡¢ÆÚÅÎÒ©ÀíÊý¾ÝµÄ¡°±¨Ïþ¡±µÈ·½Ãæ¡£ÏÖÔÚÌ죬×ðÁú¿Ê±Ñз¢³ÌÐò¿ÉÄܸı䲻´ó£¬µ«ÒªÇ¿µ÷µÄÊÇ£¬¶Ô°ÐµãµÄ¡°ÏÓÒÉ¡±¿Éνʱ¿Ì²»¸ÒµôÒÔÇáÐÄ£¬ÒªÖªµÀ£¬ÊÖÒÕÉϵĹýʧ¿ÉÒÔÖð½¥Ìî²¹£¬µ«Æ«ÏòÉϵĹýʧ£¬¾ø¶ÔÊÇÖÂÃüµÄ¡£¹Ê¶ø£¬Ò©ÎﻯѧµÄÊÂÇéÒ²¾Í¸ü¶àµÄҪȥѧϰҩÀíѧ¡¢·Ö×ÓÉúÎïѧµÈÏà¹ØÑ§¿ÆµÄÄÚÈÝ£¬Ö»Óжàѧ¿ÆµÄ¾ÙÐÐÔÓôÛ£¬²¢ÐγÉÒ»¶¨µÄÌ«¼«£¬Ò²Ðí²Å»ª¸üºÃµÄÒâ»á¡°°Ðµã¡±¡¢Òâ»á¡°ÐÂÒ©¡±£¡
²Î¿¼ÎÄÏ×£º
1. ZC Li£¬WQ Zhong£¬ZQ Liu£¬etal. Large-scale identification of potential drugtargets based on the topological features of human protein-protein interaction network [J]. Analytica Chimica Acta£¬ 2015£¬ 871: 18-27.
2. P Kumari£¬A Nath£¬R Chaube. Identification of human drug targets using machine-learning algorithms [J].Computers in Biology &Medicine£¬2015£¬56 (56C) :175-181.
3. CM Pichler£¬J Krysiak£¬R Breinbauer. Target identification of covalently binding drugs by activity-based protein profiling [J]. Bioorganic & Medicinal Chemistry£¬2016£¬24 (15) :3291.
4. R Breinbauer. Target identification of small molecule drugs and chemical probes [J]. Bioorganic & Medicinal Chemistry£¬2016£¬24 (15): 3231.
5. T Katsila£¬GA Spyroulias£¬GP Patrinos£¬et al. Computational approaches in target identification and drug discovery [J]. Computational& Structural Biotechnology Journal£¬2016£¬14: 177-184.
6. WMMVD Broeck. Chapter 3-Drug Targets£¬Target Identification£¬Validation£¬and Screening [J]. Practice of Medicinal Chemistry£¬2015: 45-70.
7. ¶Å¹Ú»ª.Ò©Îï°ÐµãµÄ·¢Ã÷ºÍÈ·Ö¤Ñо¿[C]. ÖйúÒ©Àíѧ»áҩѧÉú³¤Ç°ÑØÂÛ̳£¬ 2008:24-26.
8. ÕÅÒô£¬ÍõËÉ¿¡£¬µóÌìϲ.Ò©Îï°ÐµãµÄÉú³¤Ô¶¾°¼°ÐèÒª½â¾öµÄÒªº¦ÎÊÌâ [J]. ÖйúÐÂÒ©ÔÓÖ¾£¬2009 (19): 1834-1837.
9. ´Þ´óÃ÷.Ò©Îï°ÐµãɸѡµÄÑо¿ [J]. ÖйúÎÀÉú¹¤Òµ£¬2013 (14): 187-187.
10. ÅÓÏþ´Ô£¬Áõ°¬ÁÖ£¬¶Å¹Ú»ª.Ò©Îï°ÐµãÊý¾Ý¿âµÄÓ¦ÓÃÏ£Íû[J].ÖйúҩѧÔÓÖ¾£¬2014£¬49(22): 1969-1972.